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Purpose: The purpose of this study was to utilize an objective endpoint analysis of aneurysm treatment, which is based on
the primary objective of aneurysm repair, and to apply it to a consecutive series of patients undergoing open and
endovascular repair.
Method: Aneurysm-related death was defined as any death that occurred within 30 days of primary aneurysm treatment
(open or endovascular), within 30 days of a secondary aneurysm or graft-related treatment, or any death related to the
aneurysm or graft at any time following treatment. We reviewed 417 consecutive patients undergoing elective infrarenal
aortic aneurysm repair: 243 patients with open repair and 174 patients with endovascular repair.
Results: There was no difference between the groups (open vs endovascular) with regard to mean age standard deviation
(73  8 years vs 74  8 years) or aneurysm size (64  2 mm vs 58  10 mm) (P  not significant [NS]). The 30-day
mortality for the primary procedure after open repair was 3.7% (9/243) and after endovascular repair was 0.6% (1/174,
P < .05). The 30-day mortality for secondary procedures after open repair was 14% (6/41) compared to 0% after
endovascular repair (P < .05). The aneurysm-related death rate was 4.1% (10/243) after open surgery and 0.6% (1/174)
after endovascular repair (P < .05). Mean follow-up was 5 months longer following open repair (P < .05). Secondary
procedures were performed in 41 patients following open surgery and 27 patients following endovascular repair (P 
NS). Secondary procedures following open repair were performed for anastomotic aneurysms (n  18), graft infection
(n  6), aortoenteric fistula (n  5), anastomotic hemorrhage (n  4), lower extremity amputation (n  4), graft
thrombosis (n  3), and distal revascularization (n  1). Secondary procedures following endovascular repair consisted
of proximal extender cuffs (n 11), distal extender cuffs (n 11), limb thrombosis (n 3), and surgical conversion (n
2). The magnitude of secondary procedures following open repair was greater with longer operative time 292  89
minutes vs 129 33 minutes (P < .0001), longer length of stay 13 10 days vs 2 2 days (P < .0001) and greater blood
loss 3382  4278 mL vs 851  114 mL (P < .0001).
Conclusions: The aneurysm-related death rate combines early and late deaths and should be used as the primary outcome
measure to objectively compare the results of open and endovascular repair in the treatment of infrarenal abdominal aortic
aneurysms. In our experience, endovascular aneurysm repair reduced the overall aneurysm-related death rate when
compared to open repair. Secondary procedures are required after both open and endovascular repair. However, the
magnitude, morbidity, and mortality of secondary procedures are reduced significantly with endovascular repair. (J Vasc
Surg 2002;36:297-304.)
The natural history of aortic aneurysms is to enlarge
and rupture. Death was the inevitable consequence of
aneurysm rupture until 50 years ago when Charles Dubost
first treated an aortic aneurysm with an aortic homograft
thus preventing rupture.1 Since that time, direct open
surgical repair has been perfected and accepted as the
standard of care. However, the procedure can cause death
in 2% to 7% of patients with significant morbidity and
disability.2-4 Outcome analysis of open aneurysm repair has
been primarily focused on operative mortality rates with
risk-benefit analysis of surviving the operation versus the
risk of aneurysm rupture. It is commonly assumed that
following open surgical repair the patient is no longer at risk
for aneurysm-related death. However, secondary proce-
dures to treat recurrent aneurysms, pseudoaneurysms, graft
thrombosis, graft infection, and aortoduodenal fistula can
cause death but are not included in the primary endpoint
analysis.
Parodi et al5 introduced endovascular aneurysm repair
10 years ago as a less invasive treatment. Controlled clinical
trials have consistently shown a significant reduction in
morbidity with endovascular repair.6-9 However, there is
uncertainty regarding the long-term outcome of endovas-
cular repair. In 1999, the U.S Food and Drug Administra-
tion (FDA) approved two endoluminal devices with a re-
quirement of 5-year surveillance of the aneurysm and
endovascular device. Surveillance of endovascular patients
has now been extended to life-long because of reports of
aneurysm ruptures and deaths.10-12 Similar close follow-up
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strategies have not been applied to open surgical repair,
despite the fact that there are a number of reports of deaths
caused by aneurysm rupture and graft failure.13-16 Thus,
neither of the currently available methods of treating aneu-
rysms is entirely effective in preventing aneurysm death.
The purpose of this study is to propose an endpoint for
objective analysis in comparing open and endovascular
aneurysm repair. We defined aneurysm-related death as any
death that occurred within 30 days of primary aneurysm
treatment, within 30 days of a secondary aneurysm or
graft-related treatment, or any death related to the aneu-
rysm or graft at any time following treatment. This end-
point analysis can be used for both open and endovascular
treatment. We applied this primary endpoint analysis to
417 consecutive patients undergoing primary infrarenal
aneurysm repair at a single institution. We also reviewed all
secondary procedures performed following open and endo-
vascular repair.
PATIENTS AND METHODS
Patients. We reviewed all patients with infrarenal
aortic aneurysms treated from July 1993 through June
2000 at Stanford University Medical Center. Fifty-nine
patients with ruptured abdominal aortic aneurysms were
excluded from further analysis. Primary nonruptured infra-
renal aortic aneurysm repair was performed in 417 patients,
including 243 open surgical repairs (58%) and 174 endo-
vascular repairs (42%). Twenty-one patients had previously
undergone open aneurysm repair elsewhere and presented
with a recurrent aneurysm or graft complication requiring
open surgical repair. Three patients had previously under-
gone endovascular aneurysm repair elsewhere and required
a secondary endovascular procedure. Thus, a total of 264
patients underwent open aortic aneurysm repair and 177
patients underwent endovascular repair. From 1993 to
1996, only open aneurysm repair was available to patients.
Beginning in 1996, endovascular repair using the AneuRx
stent graft (Medtronic AVE, Santa Rosa, Calif) became
available through the U.S. AneuRx multicenter clinical
trial. After FDA market approval in 1999, patients were
treated with use of the commercial device.
The treating surgeon determined the selection of open
or endovascular repair. All treated patients were prospec-
tively entered into a vascular registry. Patients considered
for endovascular repair were presented to a panel of vascular
surgeons who reviewed the aneurysm morphology on the
basis of cross-sectional imaging with or without aortogra-
phy and determined whether endovascular repair was ap-
propriate. Criteria for endovascular repair required a prox-
imal aortic neck length of 10 mm and aortic neck
diameter of 26 mm.
Technique of primary open repair. Surgical tech-
nique was based on surgeon preference with 55%(135/
243) of patients undergoing transperitoneal repair and 45%
(108/243) retroperitoneal repair. All patients received syn-
thetic grafts. Dacron grafts were utilized in 239 (98%) and
polytetrafluoroethylene in four (2%). The most common
open vascular reconstruction was a bifurcated aortoiliac
graft in 121 (50%), aortic tube graft 78 (32%), and aorto-
bifemoral bypass graft 44 (18%). All patients had infrarenal
aneurysms and these were repaired using an infrarenal
cross-clamp.
Technique of primary endovascular repair. The
AneuRx bifurcated stent graft was utilized for all endovas-
cular repairs; this procedure was performed under general
anesthesia in 167 (96%) patients and epidural anesthesia in
seven patients (4%). Bilateral transverse groin incisions were
used to expose both common femoral arteries in 168 (97%)
patients, with retroperitoneal exposure for external or com-
mon iliac artery access in six patients (3%). The first 23
endovascular patients received the early prototype stiff bi-
furcation stent graft and the following 151 patients re-
ceived the flexible segmented bifurcation stent graft.
Monitoring and surveillance. Patients who received
endovascular grafts were scheduled for routine follow-up
with abdominal roentgenograms, duplex scanning, and/or
computed tomographic or magnetic resonance angiogra-
phy at 1, 6, and 12 months and then yearly thereafter.
Surveillance following open aneurysm repair consisted of
scheduled routine clinical follow-up at 1, 6, and 12 months
and then yearly thereafter. Computed tomographic an-
giography, duplex scanning, and catheter angiography im-
aging was performed in patients who underwent open
surgery as clinically indicated.
Primary procedure. The primary procedure was de-
fined as the first treatment procedure used to exclude the
abdominal aortic aneurysm and was either open or endo-
vascular repair in each patient.
Primary procedure–related mortality. Primary pro-
cedure–related mortality was defined as death within 30
days of the primary procedure or death within the same
hospitalization if it occurred after 30 days. The primary
procedure–related mortality for this report will include only
those patients who had their primary repair at Stanford
University Medical Center.
Secondary procedure. A secondary procedure was
defined as any surgical procedure following the primary
procedure that was directly related to the aneurysm, the
vascular graft, or the endoluminal device. Procedures were
classified as transabdominal, transfemoral, or peripheral.
We excluded seven secondary procedures performed on
seven patients (six open surgery and one endovascular) that
were the result of treatment-related morbidity but unre-
lated to the aneurysm or graft. These included two balloon
angioplasties and stenting of coronary lesions, one follow-
ing an endovascular and one following an open repair; two
tracheostomies following open repair; two dialysis access
catheters following open repair; and one cardiac pacemaker
placed following open repair.
We also excluded all nonsurgical interventions related
to the graft or aneurysm. These included 12 diagnostic
arteriograms, one balloon angioplasty and stenting of a
femoral limb, and one esophagogastroduodenoscopy in 13
patients following open surgery. We also excluded 10 diag-
nostic arteriograms, six coil embolizations, and one throm-
JOURNAL OF VASCULAR SURGERY
August 2002298 Arko et al
bin injection of the aneurysm sac in 16 patients following
endovascular repair.
Secondary procedure–related mortality. Secondary
procedure–related mortality was defined as death within 30
days of the secondary procedure or death within the same
hospitalization if it occurred after 30 days.
Aneurysm-related death. Aneurysm-related death
was defined as primary procedure–related mortality plus
secondary procedure–related mortality plus any death re-
lated to the aortic graft or aneurysm rupture at any time
during follow-up.
Statistical Analyses. Results are reported as the
mean  standard deviation. Comparisons between groups
were performed using the Student t test, Fisher exact test,
and Wilcoxon rank-sum test as appropriate. Rates of sur-
vival free of secondary procedures and freedom from aneu-
rysm-related death were estimated by the Kaplan-Meier
method.
RESULTS
There was no statistically significant difference be-
tween the open and endovascular patients who had their
primary procedure at Stanford with regard to age 73.4
7.8 years (range, 50-93 years) and 73.5  8.1 years
(range, 45-96 years) or gender, 83% and 86% were male,
respectively (P  not significant [NS]). The mean aneu-
rysm size was 63.7  1.5 mm (range, 40-115 mm) for
open repair and 57.6  9.4 mm (range, 40-87 mm) for
endovascular repair (P  NS). Patient demographics are
shown in Table I. Mean length of follow-up was 16.6 
12.8 months (range, 1-69 months) for open surgery and
11.8  9.5 months (range, 1-48 months) for endovas-
cular repair (P  .05).
Primary procedure mortality. The 30-day primary
procedure mortality for all patients who had their primary
aneurysm procedure at Stanford was 2.4% (10/417). The
30-day primary procedure mortality for open surgery was
3.7% (9/243) and for endovascular repair was 0.6% (1/
174) (P .05). The cause of death following open surgery
was cardiac arrest in three patients, respiratory failure in
three patients, multiple-system organ failure in two pa-
tients, and stroke in one patient. The cause of the single
death following primary endovascular aneurysm repair was
myocardial infarction that occurred 3 weeks after hospital
discharge following uneventful endovascular repair (Table
II).
Secondary procedure mortality. The 30-day sec-
ondary procedure mortality following open surgery was
14%(6/41) and for endovascular repair was zero of 27 (0%)
(P  .05%). Of the 41 open secondary procedures, 20
patients had their primary procedure performed at Stanford
and 21 patients had their primary procedure elsewhere.
Among the 20 patients who had their primary procedure at
Stanford, there was one (5%) death. Among the 21 patients
whose primary procedure was elsewhere, there were 5
(24%) deaths following the secondary open aneurysm re-
pair. The causes of death after the primary and secondary
procedure are listed in Table II. The causes of death fol-
lowing secondary procedures in open surgery were multi-
ple-system organ failure in three patients, cardiac arrest in
two patients, and respiratory failure in one patient.
Aneurysm-related death. The aneurysm-related
death rate following open aortic aneurysm repair was
4.1%and included nine deaths following the primary pro-
cedure and one death following a secondary procedure
among 243 patients treated at Stanford. Aneurysm-related
death rate following endovascular repair was significantly
lower at 0.6%, with a single death among 174 patients
undergoing primary and secondary procedures at Stanford
(P  .05) (Table III). Kaplan-Meier estimates for freedom
from aneurysm-related death at 3 years was 94% for open
repair and 99% for endovascular repair (P .056) (Fig 1) in
patients who had their primary and secondary procedures at
Stanford. The aneurysm-related death rate is 5.7% (15/
264) following open surgery and 0.5% (1/177) (P .05) if
all outside patients and their secondary procedures are
included.
Primary procedure morbidity. The primary proce-
dure morbidity rate for the entire group of patients repaired
at Stanford was 10.5% (44/417). There was no difference
in morbidity rate following the primary procedure for open
11% (27/243) or endovascular repair 10% (17/174). The
morbidities following the primary and secondary procedure
are listed in Table IV.
Secondary procedure morbidity. The procedure
morbidity rate following secondary procedures was 17%(7/
41) in the open group and 7% (2/27) following endovas-
cular (P  NS). However, the secondary procedure mor-
bidity following endovascular repair consisted of local
wound complications, whereas the secondary procedure
morbidity following open repair was comprised of systemic
complications (cardiac, respiratory, and renal) (Table IV).
Secondary procedures. There was no difference in
the incidence of secondary procedures following open,
8.2% (20/243), or endovascular repair, 13.7% (24/174)
(P  NS), in patients who had their primary procedure at
Stanford University. Furthermore, there was no difference
in the incidence of secondary procedures between open,
15.5% (41/264), and endovascular repair, 15.2% (27/
177), when those patients who had their primary procedure
elsewhere were included. Kaplan-Meier estimates for free-
dom from secondary procedures at 1 and 3 years following
Table I. Preoperative patient characteristics
Characteristic
Open
(n  243)
Endovascular
(n  174) P value
Coronary artery disease 184 (76) 137 (79) NS
Hypertension 136 (56) 106 (61) NS
COPD 114 (47) 92 (53) NS
Diabetes mellitus 75 (31) 62 (36) NS
Chronic renal failure 14 (6) 12 (7) NS
Data are n (%) of patients and include only those patients who had their
primary procedure performed at Stanford University.
COPD, chronic obstructive pulmonary disease.
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open and endovascular repair were 97%, 93% and 94% ,
55%, respectively. When the early prototype stiff bifurca-
tion AneuRx stent graft (not commercially available) is
excluded from the analysis, there is no difference in free-
dom from secondary procedures at 1 and 3 years by Kaplan
Meier analysis (Fig 2) for open (97% and 93%) and endo-
vascular repair (100% and 90%).
Secondary procedures following open repair were per-
formed for anastomotic pseudoaneurysm (n  18), in-
fected graft (n  6), aortoenteric fistula (n  5), anasto-
motic hemorrhage (n  4), lower extremity amputation
(n 4), graft thrombosis (n 3), and distal revasculariza-
tion (n 1). These secondary procedures presented within
30 postoperative days in 11 patients (4.2%) and by late
follow-up in 30 patients (11.3%) (Table V).
Secondary procedures following endovascular repair
included placement of proximal extender cuffs (n  11)
and distal extender cuffs (n  11) to secure stent–graft
fixation, thrombectomy for unilateral limb thrombosis
(n  3), and surgical conversion (n  2). These complica-
tions presented within 30 postoperative days in five patients
(2.8%) and by late follow-up in 27 patients (15.2%) (Table
VI).
Magnitude of secondary interventions. Secondary
procedures following open aneurysm repair included 27
intraabdominal procedures, nine groin procedures, and five
peripheral procedures (Table V). Secondary procedures
following endovascular aneurysm repair included two intra-
abdominal procedures and 25 groin procedures (Table VI).
Secondary procedures following open surgery had signifi-
cantly longer mean operative time (292  89 minutes for
open vs 129  33 minutes for endovascular) (P  .0001),
more blood loss (3382 4278 mL for open vs 851 114
mL for endovascular) (P  .0001), and longer hospital
length of stay (13.1  9.9 days for open vs 2.1  1.6 days
for endovascular) (P  .0001).
DISCUSSION
The objective of infrarenal abdominal aortic aneurysm
repair is to prevent rupture and death. Successful aneurysm
treatment prolongs life only if aneurysm rupture was des-
tined to occur. It is currently not possible to accurately
predict which aneurysms will rupture, although the risk
increases with increasing aneurysm size.17-19 Thus prolon-
gation of life is not a primary objective of aneurysm repair,
but rather the goal is prevention of premature death result-
ing from aneurysm rupture. To objectively compare two
procedures (open and endovascular) to treat infrarenal
abdominal aortic aneurysm it is important to utilize the
same primary outcome measure for both treatment groups.
We defined this outcome measure as aneurysm-related
death rate. Aneurysm-related death considers deaths
caused by the aneurysm itself (treated or untreated) as well
as any mortality caused by treatment (primary or second-
ary). We then analyzed the mortality directly attributed to
the aneurysm or its repair for both open and endovascular
surgery.
We found that patients undergoing open surgical repair
had a seven-fold higher risk of aneurysm-related death than
those patients undergoing endovascular repair. This risk is
the result of significantly higher 30-day operative mortality
for both the primary procedure as well as for secondary
surgical procedures. At 3 years, the freedom from aneu-
rysm-related death for patients who had their primary and
secondary procedures at Stanford was 99% for patients
Table II. Procedure-related mortality following open and endovascular aneurysm repair*
Open Endovascular P value
Primary procedure 3.7% (9/243) 0.6% (1/174) .05
Cardiac 3 1
Pneumonia 2 0
Multisystem organ failure 2 0
Pulmonary embolism 1 0
Stroke 1 0
Secondary procedure 14% (6/41) 0/27 .05
Multisystem organ failure 3 0
Cardiac 2 0
Respiratory failure 1 0
*Data are number of patients. Includes only those patients who had their procedure performed at Stanford University.
Table III. Aneurysm-related death rate following open and endovascular repair*
Open surgery
(n  243)
Endovascular repair
(n  174) P value
Primary procedure mortality 3.7% (9/243) 0.6% (1/174) .05
Secondary procedure mortality 5% (1/20) 0 (0/24) NS
Aneurysm related death rate 4.1% (10/243) 0.6% (1/174) .05
*The aneurysm-related death rate was calculated using only those patients who had their primary and secondary procedure at Stanford University.
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undergoing endovascular repair and 94% for patients with
open repair, a difference that nearly reached statistical sig-
nificance (P  .056). Analysis beyond 3 years was not
performed with Kaplan-Meier analysis, as the number of
endovascular patients with 4-year follow-up was small.
In our experience, 8% of patients undergoing open
surgery required a secondary procedure. Secondary proce-
dures following open surgery are often catastrophic, with a
much higher mortality rate than with the primary proce-
dure.13-16 The mortality rate of 14% for patients undergo-
ing secondary operations following open aortic aneurysm
repair compares favorably to that reported in the literature.
Hallet et al13 reported a graft-related complication rate of
9.4% following open aneurysm repair, with a 28% (8/29)
Table IV. Procedure related morbidity following open and endovascular aneurysm repair
Open Endovascular P value
Primary procedure 11.1% (27/243) 9.7% (17/174) NS
Cardiac (CHF, MI, arrhythmia) 15 10
Pneumonia/PE 6 0
TIA 1 1
ATN renal failure (transient) 4 1
Local (wound seroma) 1 5
Secondary procedure 17% (7/41) 7% (2/27) NS
Cardiac 3 0
Pneumonia 2 0
ATN renal failure (transient) 2 0
Local (wound seroma) 0 2
Data are number of patients. ATN, author to provide; CHF, congestive heart failure; MI, myocardial infarction; PE, pulmonary edema; TIA, transient ischemic
attack.
Fig 1. Kaplan-Meier estimates of freedom from aneurysm-related death following endovascular and open repair in
patients who had their primary procedure performed at Stanford University.
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mortality among patients treated for graft-related compli-
cations after open surgery. In this population-based study
of patients from Olmsted County, Minnesota, the primary
procedure 30-day mortality was 5% in 234 elective infrare-
nal aneurysm repairs. The mortality rate for open aneurysm,
including emergent aneurysms, was 9.4%. Thus, the aneu-
rysm-related death rate was 12% (37/307) for all patients
and 8.5% (20/234) if emergent cases were excluded.13
This rate was slightly higher than the 4.1% aneurysm-
related death rate for patients undergoing open infrarenal
aneurysm repair in our own series.
Johnston et al14 and the Canadian multi-center aneu-
rysm study group reported a 6-year experience with a late
aneurysm death rate of 1.5%.14 Primary procedure mortal-
ity among 680 patients was 5.4% and aneurysm-related
death rate was 5.8%. Plate et al15 reported a late death rate
of 6.3% associated with complications following aneurysm
repair. Crawford et al16 reported a 3% late death rate
associated with secondary interventions and complications
following aneurysm repair during a 25-year experience,
with a mean follow-up of 4.5 years. Thirty-day mortality
among 860 patients was 4.8%, resulting in a 7.8% aneu-
rysm-related death rate.16 These deaths resulted from late
complications such as recurrent aneurysm formation, false
aneurysms, aortoenteric fistula formation, and graft infec-
tions.
In our analysis of aneurysm-related death, we com-
pared patients undergoing elective open and endovascular
aneurysm repair while specifically excluding patients who
presented with ruptured abdominal aortic aneurysms.
There were 59 such patients during the study period with a
30-day mortality of 27% (16/59). All patients were treated
with open repair. In this study comparing open and endo-
vascular repair, there were no patients who underwent
endovascular repair for ruptured aneurysms. To include
these patients would have unfairly increased the aneurysm-
related death rate in the open surgery group since there was
not an equivalent cohort in the endovascular group.
The incidence of secondary procedures following en-
dovascular repair has been reported by a number of inves-
tigators.20-24 The Eurostar collaborators22 have reported
an 18% incidence of secondary interventions following
endovascular repair at a mean of 14 months and suggest
caution in the broad application of endovascular repair.
However, the majority of devices implanted were Vanguard
(51%) and Stentor (24%), devices that are no longer avail-
Fig 2. Kaplan-Meier survival curve for freedom from secondary procedures comparing open surgery to the current
flexible bifurcated AneuRx stent graft.
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able for implantation because of defined failure modes.22
Outcomes following endovascular repair may be device
specific and conclusions drawn from one device experience
may not reflect what can be expected from another. Al-
though the need for a secondary procedure following open
surgery is usually mandated by a clinically apparent graft-
related complication such as pseudoaneurysm, graft throm-
bosis, or infection, the need for a secondary procedure
following endovascular repair is less clear. For example,
secondary procedures are often performed for endoleaks of
variable significance. Thus the true necessity and incidence
is not yet known.
In our own series, using a single commercially available
endograft, the AneuRx stent graft, we found that freedom
from secondary procedures at 3 years was 90% by use of
Kaplan Meier analysis, and was no different from open
repair (93%) at 3 years. Secondary procedures were per-
formed earlier in patients following endovascular repair and
typically required only groin procedures. Secondary proce-
dures following open aneurysm usually required intraab-
dominal exploration. The increased magnitude of the sec-
ondary procedures following open surgery is further
confirmed by higher mortality rate, significantly longer
operative time, increased blood loss, and greater length of
stay following the procedure. The major morbities follow-
ing open secondary surgery included cardiac, respiratory,
and renal complications compared to predominantly local
wound complications following secondary endovascular
procedures.
There are several weaknesses with the present study.
The first is that follow-up after open surgery is 5 months
longer than that after endovascular repair, raising the pos-
sibility that longer follow-up accounts for a disproportion-
ate number of secondary procedures after open surgery.
However, the open surgery group was treated with a stable,
well-established procedure, whereas the endovascular
group was treated with a new procedure including a learn-
ing curve. The early endovascular experience also included
a prototype stiff bifurcated stent graft, which is no longer
clinically available. If we exclude our early experience with
the stiff bifurcation design of the AneuRx stent graft, then
freedom from secondary procedures is the same for open
and endovascular repair (Fig 2). Nearly half of the patients
with the stiff design needed a secondary procedure com-
pared to only 12% in patients with the flexible stent–graft
design.23
The second weakness is that the study period includes a
period when only open repair was performed and when
endovascular repair was not available. Furthermore, when
both procedures were available, not all patients were can-
didates for both open and endovascular repair. Thus it is
possible that differences in patient selection could bias the
results. On the one hand, patients who were not anatomic
candidates for endovascular repair were treated with open
surgical repair. This potentially skews more complex and
difficult aneurysms to open repair; however, all open sur-
gery patients were treated with use of an infrarenal aortic
cross-clamp. It is not known whether this potential of
increased morphologic complexity results in a greater peri-
operative risk or a higher long-term open surgery failure
rate. At the same time, patients at high operative risk were
specifically selected for endovascular repair even if morpho-
logic selection criteria were marginal because of the high
risk of open repair. This would present potential adverse
selection bias against endovascular repair. Although there is
no statistical evidence for increased risk factors in the endo-
vascular group, many individuals in that group were not
deemed to be candidates for open surgical repair. This may
explain the observation that there was no difference in
long-term survival in our series and no difference in mor-
tality rate between open and endovascular repair in pro-
spective clinical trials.6-9
Long-term studies of open repair have reported late
graft complications in 3% to 10% of patients.13-16 However,
many patients are lost to follow-up because patients treated
in referral centers may not return for follow-up. In our own
series, patients who were lost to follow-up in the open
group may have had graft-related complications that were
treated at other institutions. Similarly, our open surgical
Table V. Secondary procedures following open
aneurysm repair
Procedure
Stanford
patients (n
 20)
Outside
patients*
(n  21)
All
patients
(n  41)
Intraabdominal
Anastomotic
pseudoaneurysm
3 11 14
Infected graft 2 4 6
Aortoenteric fistula 0 5 5
Anastomotic hemorrhage 4 0 4
Femoral
Femoral pseudoaneurysm 3 1 4
Graft thrombosis 3 0 3
Peripheral
Lower extremity amputation 4 0 4
Distal revascularization 1 0 1
Data are number of patients.
*Outside patients had their primary procedure performed at another insti-
tution.
Table VI. Secondary procedures following endovascular
aneurysm repair
Procedure
Stanford
patients
(n  24)
Outside
patients*
(n  3)
All
patients
(n  27)
Intraabdominal
Surgical conversion 2 0 2
Femoral
Proximal extender cuff 9 2 11
Distal extender cuff 10 1 11
Limb thrombosis 3 0 3
Data are number of patients.
*Outside patients had their primary procedure performed at another insti-
tution.
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series included 21 patients who had previously undergone
open aortic aneurysm repair at a different institution. Thus,
the true incidence of secondary operations following open
surgical repair is unclear. This was not the case for patients
in the endovascular group because the majority were part of
an ongoing clinical trial with 100% follow-up. Long-term
follow-up of surgical patients usually does not include the
radiographic scrutiny that is essential to the detection of
occult anastomotic pseudoaneurysms. Therefore, the graft-
related complications of open repair may be underesti-
mated.
In conclusion, we defined aneurysm-related death as
death within 30 days of a primary treatment procedure;
death within 30 days of any secondary treatment proce-
dure; or death related to aneurysm rupture, the vascular
graft, or endovascular device. This primary outcome mea-
sure should be used as the objective endpoint to compare
the results of open and endovascular repair in the treatment
of infrarenal abdominal aortic aneurysms. In our experi-
ence, endovascular aneurysm repair has a significantly lower
aneurysm-related death rate when compared to open sur-
gical repair.
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